CEO INTERVIEW Will we have enough vaccines for COVID-19? [VIDEO]
Video by Lee Min-young, Kim Kang-minFor almost a year, world has been fighting a battle against the COVID-19 pandemic, a truly unprecedented, once-in-a-century health crisis, and while many countries hoped they were past the worst, many, including South Korea, are now grappling with new outbreaks. However, in an attempt to create COVID-19 vaccines and end this health crisis there has been an incredible level of cooperation and rapid mobilization in the biotech world on a global scale. The Korea Times sat down with Francis Van Parys, commercial vice president of Cytiva Asia Pacific, to learn more about how the scientific community is responding to the pandemic and the great demand for COVID-19 vaccines from around the world. Cytiva is the world's leading provider of technologies and equipment for bio-manufacturers, helping them to produce treatments quickly and efficiently. Cytiva is currently teaming up with numerous biotech companies including biotech giants in Korea to expedite COVID-19 vaccine development and manufacturing.Below is the full transcript of the interview with Francis
Jan 4, 2021By Lee Min-young